Glen Santangelo

Aug 21, 2026

On Aug 21, 2026, HIMS was given a Overweight rating by Glen Santangelo, with a target price of 35. Despite the Buy call, shares fell from 27.51 to 27.51, challenging the optimistic stance.

Aug 21, 2026

On Aug 21, 2026, Glen Santangelo published a Overweight outlook on CTEV, with a target of 40. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 35.98.

Aug 19, 2026

Glen Santangelo on Aug 19, 2026 assigned COLL a Overweight rating, with a price target of 48. The call has struggled to gain traction, with shares losing 20.84%.

Aug 19, 2026

On Aug 19, 2026, Glen Santangelo reaffirmed MCK with a Overweight rating, targeting 1000. Market indecision has kept the 1000 target in a holding pattern.

Aug 05, 2026

On Aug 05, 2026, Glen Santangelo initiated coverage on INDV with a Overweight rating and target of 43. The Buy call has yet to be validated as shares remain 8.51 away from the target.

Jun 11, 2026

On Jun 11, 2026, NVST was evaluated by Glen Santangelo, who gave a Overweight rating and target of 32. So far, the Buy call awaits clearer momentum, with shares flat at 25.55.

Jun 10, 2026

Glen Santangelo rated COR as Overweight on Jun 10, 2026, setting a price target of 350. The call has proven timely, with shares rising 14.34% toward the price target of 350.

Jun 01, 2026

MDLN received a Overweight rating from Glen Santangelo on Jun 01, 2026, aiming for 45. The rating hasn’t played out as hoped, with the stock trading 9.01% below expectations.

May 20, 2026

On May 20, 2026, Glen Santangelo published a Overweight outlook on WAY, with a target of 25. Shares gained 22.18%, underscoring the accuracy of the bullish outlook toward 25.

May 20, 2026

Glen Santangelo on May 20, 2026 assigned AMRX a Overweight rating, with a price target of 16. The Buy call aligned well with market performance, producing a gain of 39.08%.

May 19, 2026

On May 19, 2026, Glen Santangelo reaffirmed VTRS with a Overweight rating, targeting 22. Market indecision has kept the 22 target in a holding pattern.

May 18, 2026

PGNY was rated Overweight by Glen Santangelo on May 18, 2026, with a price objective of 27. A bullish response from the market helped close the gap of -0.35 to the target.

May 06, 2026

Glen Santangelo issued a Overweight recommendation for TEVA on May 06, 2026, price target set at 40. The target of 40 remains in play, though confirmation will depend on future moves.

Mar 27, 2026

On Mar 27, 2026, PHAT was evaluated by Glen Santangelo, who gave a Overweight rating and target of 18. Investors saw limited payoff as shares fell short of the 18 target.

Mar 17, 2026

On Mar 17, 2026, Glen Santangelo published a Overweight outlook on ALGN, with a target of 200. Market action contradicted the Buy thesis, as shares slipped to 150.82.

Feb 24, 2026

On Feb 24, 2026, Glen Santangelo initiated coverage on CAH with a Overweight rating and target of 258. Neutral price movement of 3.81% leaves room for interpretation.

Feb 18, 2026

Glen Santangelo issued a Overweight recommendation for HQY on Feb 18, 2026, price target set at 118. Investors following the Buy call captured upside momentum, with shares now at 96.26.

Feb 05, 2026

On Feb 05, 2026, IDXX was evaluated by Glen Santangelo, who gave a Overweight rating and target of 800. Investors saw limited payoff as shares fell short of the 800 target.

Dec 09, 2025

Glen Santangelo rated AS as Overweight on Dec 09, 2025, setting a price target of 49. The stock has underperformed, dropping 27.43% despite the bullish target of 49.

Dec 09, 2025

On Dec 09, 2025, XERS was given a Overweight rating by Glen Santangelo, with a target price of 9. The stock rallied 6.28% after the rating, narrowing the gap to the target of 9 and validating the bullish stance.

Dec 09, 2025

TARS received a Overweight rating from Glen Santangelo on Dec 09, 2025, aiming for 100. Price action was muted, as shares hovered around 79.31 despite the bullish outlook.

Dec 09, 2025

On Dec 09, 2025, Glen Santangelo published a Overweight outlook on HSIC, with a target of 86. Shares gained 18.70%, underscoring the accuracy of the bullish outlook toward 86.

Dec 09, 2025

Glen Santangelo on Dec 09, 2025 assigned ELAN a Overweight rating, with a price target of 30. The Buy call aligned well with market performance, producing a gain of 13.36%.

Dec 09, 2025

On Dec 09, 2025, Glen Santangelo reaffirmed ANIP with a Overweight rating, targeting 100. Shares slid 14.06% despite the recommendation, highlighting downside risks.